HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.

Abstract
Neuregulin-1 (NRG1) is implicated in the etiology or pathology of schizophrenia, although its biological roles in this illness are not fully understood. Human midbrain dopaminergic neurons highly express NRG1 receptors (ErbB4). To test its neuropathological role in the neurodevelopmental hypothesis of schizophrenia, we administered type-1 NRG1 protein to neonatal mice and evaluated the immediate and subsequent effects on dopaminergic neurons and their associated behaviors. Peripheral NRG1 administration activated midbrain ErbB4 and elevated the expression, phosphorylation and enzyme activity of tyrosine hydroxylase (TH), which ultimately increased dopamine levels. The hyperdopaminergic state was sustained in the medial prefrontal cortex after puberty. There were marked increases in dopaminergic terminals and TH levels. In agreement, higher amounts of dopamine were released from this brain region of NRG1-treated mice following high potassium stimulation. Furthermore, NRG1-treated mice exhibited behavioral impairments in prepulse inhibition, latent inhibition, social behaviors and hypersensitivity to methamphetamine. However, there were no gross abnormalities in brain structures or other phenotypic features of neurons and glial cells. Collectively, our findings provide novel insights into neurotrophic contribution of NRG1 to dopaminergic maldevelopment and schizophrenia pathogenesis.
AuthorsT Kato, Y Abe, H Sotoyama, A Kakita, R Kominami, S Hirokawa, M Ozaki, H Takahashi, H Nawa
JournalMolecular psychiatry (Mol Psychiatry) Vol. 16 Issue 3 Pg. 307-20 (Mar 2011) ISSN: 1476-5578 [Electronic] England
PMID20142818 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dopamine Antagonists
  • Neuregulin-1
  • Proto-Oncogene Proteins c-fos
  • Methamphetamine
  • Levodopa
  • Tyrosine 3-Monooxygenase
  • Risperidone
  • Potassium
  • Dopamine
Topics
  • Acoustic Stimulation
  • Animals
  • Animals, Newborn
  • Behavior, Animal (drug effects)
  • Biotinylation
  • Brain (drug effects, growth & development, metabolism)
  • Dopamine (metabolism)
  • Dopamine Antagonists (pharmacology)
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation, Developmental (drug effects)
  • Hearing (drug effects)
  • Immunoprecipitation
  • Levodopa (metabolism)
  • Locomotion (drug effects)
  • Methamphetamine (pharmacology)
  • Mice
  • Microdialysis (methods)
  • Neuregulin-1 (pharmacology)
  • Phosphorylation (drug effects)
  • Potassium (pharmacology)
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Reflex, Startle (drug effects)
  • Risperidone (pharmacology)
  • Social Behavior
  • Statistics, Nonparametric
  • Tyrosine 3-Monooxygenase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: